semaglutide with tirzepatide vs Tirzepatide: Which Is Better for Weight Loss? Semaglutide vs Tirzepatide for Weight

In the AMPLITUDE-O trial, 15% of patients included were also receiving sodium-glucose cotransporter 2 (SGLT2) inhibitors, yet efpeglenatide decreased the rate of MACE irrespective of whether patients were also receiving this treatment

During ER stress, GRP78, the primary regulator of UPR, dissociates from the ER compartment, activating the main PERK protein pathway

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin

Depression, gender and cellular immunity: influence of gender and severity of depression on the cellular immunity

The gastrointestinal side-effect burden is also comparable, sometimes worse at higher doses